Abiomed to Present at Morgan Stanley Global Healthcare Unplugged Conference

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 9:00am EDT

DANVERS, Mass.--(Business Wire)--
Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R.
Minogue, Chairman, President and Chief Executive Officer, will present
at the Morgan Stanley Global Healthcare Unplugged Conference on
September 9, 2008 at 9:45 a.m. ET. The conference will be held at the
Grand Hyatt in New York City, New York.

   ABOUT ABIOMED

   Based in Danvers, Massachusetts, Abiomed, Inc., is a leading
provider of medical devices that provide circulatory support to acute
heart failure patients across the continuum of care in heart recovery.
Our products are designed to enable the heart to rest, heal and
recover by improving blood flow and/or performing the pumping of the
heart. For additional information please visit: www.abiomed.com.

   FORWARD-LOOKING STATEMENTS

   This Release contains forward-looking statements, including
statements regarding development of Abiomed's existing and new
products, the Company's progress toward commercial growth, and future
opportunities and expected regulatory approvals. The Company's actual
results may differ materially from those anticipated in these
forward-looking statements based upon a number of factors, including
uncertainties associated with development, testing and related
regulatory approvals, anticipated future losses, complex
manufacturing, high quality requirements, dependence on limited
sources of supply, competition, technological change, government
regulation, future capital needs and uncertainty of additional
financing, and other risks and challenges detailed in the Company's
filings with the Securities and Exchange Commission, including the
Annual Report filed on Form 10-K and recently filed Form 10-Q. Readers
are cautioned not to place undue reliance on any forward-looking
statements, which speak only as of the date of this Release. The
Company undertakes no obligation to publicly release the results of
any revisions to these forward-looking statements that may be made to
reflect events or circumstances that occur after the date of this
Release or to reflect the occurrence of unanticipated events.

Abiomed, Inc.
Daniel J. Sutherby, 978-777-5410
Chief Financial Officer
ir@abiomed.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.